UBS Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-138,241
| Closed | -$3.27M | – | 8867 |
|
|
2023
Q4 | $3.27M | Buy |
138,241
+5,741
| +4% | +$136K | ﹤0.01% | 2391 |
|
|
2023
Q3 | $1.98M | Buy |
132,500
+78,633
| +146% | +$1.17M | ﹤0.01% | 2552 |
|
|
2023
Q2 | $590K | Sell |
53,867
-15,933
| -23% | -$174K | ﹤0.01% | 3696 |
|
|
2023
Q1 | $609K | Sell |
69,800
-215,936
| -76% | -$1.88M | ﹤0.01% | 3567 |
|
|
2022
Q4 | $1.79M | Sell |
285,736
-209,502
| -42% | -$1.31M | ﹤0.01% | 2648 |
|
|
2022
Q3 | $1.73M | Buy |
495,238
+39,973
| +9% | +$140K | ﹤0.01% | 2453 |
|
|
2022
Q2 | $1.34M | Buy |
455,265
+423,806
| +1,347% | +$1.25M | ﹤0.01% | 2668 |
|
|
2022
Q1 | $99K | Sell |
31,459
-25,683
| -45% | -$80.8K | ﹤0.01% | 4925 |
|
|
2021
Q4 | $193K | Buy |
57,142
+25,345
| +80% | +$85.6K | ﹤0.01% | 4690 |
|
|
2021
Q3 | $116K | Sell |
31,797
-4,684
| -13% | -$17.1K | ﹤0.01% | 4665 |
|
|
2021
Q2 | $159K | Sell |
36,481
-82,889
| -69% | -$361K | ﹤0.01% | 4502 |
|
|
2021
Q1 | $542K | Sell |
119,370
-9,574
| -7% | -$43.5K | ﹤0.01% | 3864 |
|
|
2020
Q4 | $740K | Buy |
128,944
+92,874
| +257% | +$533K | ﹤0.01% | 3374 |
|
|
2020
Q3 | $261K | Sell |
36,070
-342,797
| -90% | -$2.48M | ﹤0.01% | 3830 |
|
|
2020
Q2 | $1.32M | Buy |
378,867
+6,965
| +2% | +$24.3K | ﹤0.01% | 2609 |
|
|
2020
Q1 | $551K | Buy |
371,902
+287,393
| +340% | +$426K | ﹤0.01% | 3124 |
|
|
2019
Q4 | $166K | Sell |
84,509
-73,877
| -47% | -$145K | ﹤0.01% | 4711 |
|
|
2019
Q3 | $811K | Buy |
158,386
+83,586
| +112% | +$428K | ﹤0.01% | 3356 |
|
|
2019
Q2 | $536K | Sell |
74,800
-6,176
| -8% | -$44.3K | ﹤0.01% | 3500 |
|
|
2019
Q1 | $1.08M | Buy |
80,976
+45,859
| +131% | +$609K | ﹤0.01% | 2879 |
|
|
2018
Q4 | $276K | Sell |
35,117
-20,835
| -37% | -$164K | ﹤0.01% | 3884 |
|
|
2018
Q3 | $620K | Sell |
55,952
-85,629
| -60% | -$949K | ﹤0.01% | 3516 |
|
|
2018
Q2 | $1.9M | Buy |
141,581
+109,349
| +339% | +$1.47M | ﹤0.01% | 2587 |
|
|
2018
Q1 | $419K | Buy |
32,232
+23,562
| +272% | +$306K | ﹤0.01% | 3577 |
|
|
2017
Q4 | $80K | Buy |
8,670
+5,670
| +189% | +$52.3K | ﹤0.01% | 4582 |
|
|
2017
Q3 | $24K | Sell |
3,000
-1,738
| -37% | -$13.9K | ﹤0.01% | 5432 |
|
|
2017
Q2 | $27K | Buy |
4,738
+979
| +26% | +$5.58K | ﹤0.01% | 5150 |
|
|
2017
Q1 | $16K | Sell |
3,759
-3,310
| -47% | -$14.1K | ﹤0.01% | 5400 |
|
|
2016
Q4 | $12K | Buy |
7,069
+4,069
| +136% | +$6.91K | ﹤0.01% | 5872 |
|
|
2016
Q3 | $6K | Sell |
3,000
-3,128
| -51% | -$6.26K | ﹤0.01% | 6141 |
|
|
2016
Q2 | $10K | Buy |
+6,128
| New | +$10K | ﹤0.01% | 5908 |
|
|
2015
Q3 | – | Sell |
-6,771
| Closed | -$18K | – | 6991 |
|
|
2015
Q2 | $18K | Buy |
+6,771
| New | +$18K | ﹤0.01% | 5588 |
|
|
2015
Q1 | – | Sell |
-329
| Closed | -$3K | – | 6843 |
|
|
2014
Q4 | $3K | Buy |
+329
| New | +$3K | ﹤0.01% | 6529 |
|